The store will not work correctly when cookies are disabled.
ID: ALA4288751
Max Phase: Preclinical
Molecular Formula: C17H17NO7S2
Molecular Weight: 411.46
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCOC(=O)/C=C/c1c(NS(=O)(=O)c2cccs2)cc2c(c1OC)OCO2
Standard InChI: InChI=1S/C17H17NO7S2/c1-3-23-14(19)7-6-11-12(18-27(20,21)15-5-4-8-26-15)9-13-17(16(11)22-2)25-10-24-13/h4-9,18H,3,10H2,1-2H3/b7-6+
Standard InChI Key: KMEFNZHCZHNNGO-VOTSOKGWSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 411.46 | Molecular Weight (Monoisotopic): 411.0446 | AlogP: 2.86 | #Rotatable Bonds: 7 |
Polar Surface Area: 100.16 | Molecular Species: ACID | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.08 | CX Basic pKa: | CX LogP: 2.77 | CX LogD: 1.96 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.55 | Np Likeness Score: -0.92 |
References
1. (2016) Compounds, compositions and methods for inhibiting cnksr1, |
2. (2018) Methods and compositions for inhibiting cnksr1, |
3. (2016) Compounds, compositions and methods for inhibiting cnksr1, |